Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial.
Francesco Di PierroSomia IqtadarAmjad KhanSami Ullah MumtazMohsin Masud ChaudhryAlexander BertuccioliGiuseppe DerosaPamela MaffioliStefano TogniAntonella RivaPietro AllegriniSaeed KhanPublished in: International journal of general medicine (2021)
QP statistically shortens the timing of molecular test conversion from positive to negative, reducing at the same time symptoms severity and negative predictors of COVID-19.